Skip to main content
SpringerLink
Log in

Levels of serum and cerebrospinal fluid soluble CD27 in the diagnosis of leptomeningeal involvement of hematolymphoid malignancies

  • Published:
Advances in Therapy Aims and scope Submit manuscript

Abstract

Reportedly, soluble CD27 (sCD27) is a sensitive and specific marker for leptomeningeal involvement (LI) of CD27-expressing lymphoproliferations, such as B-cell non-Hodgkin’s lymphoma and chronic B-lymphocytic leukemia. On morphologic analysis of cerebrospinal fluid (CSF), one third of patients suspected of LI have false negatives, so a diagnostic marker for LI in B-cell non-Hodgkin’s lymphoma or B-lymphocytic leukemia would be extremely valuable. sCD27 was detected in the serum and CSF samples from 35 selected patients in whom 18 cases of acute lymphoblastic leukemia (ALL) (3 with LI), 7 of non-Hodgkin’s lymphoma, and 5 of acute myelogenous leukemia (3 with LI) were submitted for (immuno)morphologic detection of malignant cells and intrathecal therapy, along with samples from 5 control patients (2 submitted for epidural hemorrhage, 3 for lumbar disc protrusion). Concentrations of CSF-sCD27 were determined by enzyme-linked immunosorbent assay (PeliKine Compact Human Soluble CD27 ELISA Kit, Cat. No. M1960; Research Diagnostics Inc., Concord, Mass). The cutoff value was 350 U/mL. Serum and CSF-sCD27 concentrations above the cutoff value were not detected. Although it is unlikely that LI would be present in patients with chronic lymphoproliferation who have normal sCD27 concentrations in CSF samples, the determination of CSF-sCD27 is not sufficiently specific to allow it to serve as a reliable tumor marker.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Glass JP, Melamed M, Chernik NL, Posner JB. Malignant cells in cerebrospinal fluid (CSF): the meaning of a positive CSF cytology.Neurology. 1979;29:1369–1375.

    PubMed  CAS  Google Scholar 

  2. Hovestadt A, Henzen-Logmans SC, Vecht CJ. Immunohistochemical analysis of the cerebrospinal fluid for carcinomatous and lymphomatous leptomeningitis.Br J Cancer. 1991;62:653–654.

    Google Scholar 

  3. Weller M, Stevens A, Sommer N, Schabet M, Wietholter H. Humoral CSF parameters in the differential diagnosis of hematological CNS neoplasia.Acta Neurol Scand. 1992;86:129–133.

    PubMed  CAS  Google Scholar 

  4. Twijnstra A, Ongerboer de Visser BW, van Zanten AP. Diagnosis of leptomeningeal metastasis.Clin Neurol Neurosurg. 1987;89:79–85.

    Article  PubMed  CAS  Google Scholar 

  5. Jeffery GM, Frampton CM, Legge HM, Hart DN. Cerebrospinal fluid β-microglobulin levels in meningeal involvement by malignancy.Pathology. 1990;22:20–23.

    Article  PubMed  CAS  Google Scholar 

  6. Stucki A, Cordey A, Monai N, de Flaugergues J, Schapira M, Spertini O. Cleaved L-selectin concentrations in meningeal leukemia.Lancet. 1995;345:286–289.

    Article  PubMed  CAS  Google Scholar 

  7. Finn WG, Peterson LC, James C, Goolsby CL. Enhanced detection of malignant lymphoma in the cerebrospinal fluid by multiparameter flow cytometry.Am J Clin Pathol. 1998;110:341–346.

    PubMed  CAS  Google Scholar 

  8. Rhodes CH, Glantz MJ, Glantz L, et al. A comparison of polymerase chain reaction examination of cerebrospinal fluid and conventional cytology in the diagnosis of lymphomatous meningitis.Cancer. 1996;77:543–548.

    Article  PubMed  CAS  Google Scholar 

  9. van Oostenbrugge RJ, Hopman AH, Lenders MH, et al. Detection of malignant cells in cerebrospinal fluid using fluorescence in situ hybridization.J Neuropathol Exp Neurol. 1997;56:743–748.

    Article  PubMed  Google Scholar 

  10. Widney D, Gundapp G, Said JW, et al. Aberrant expression of CD27 and soluble CD27 (sCD27) in HIV infection and in AIDS-associated lymphoma.Clin Immunol. 1999;93:114–123.

    Article  PubMed  CAS  Google Scholar 

  11. Hintzen RQ, de Jong R, Hack CE, et al. A soluble form of the human T cell differentiation antigen CD27 is released after triggering of the TCR/CD3 complex.J Immunol. 1991;147:29–35.

    PubMed  CAS  Google Scholar 

  12. Kersten MJ, Evers LM, Dellemijn PLI, et al. Elevation of cerebrospinal fluid soluble CD27 levels in patients with meningeal localization of lymphoid malignancies.Blood. 1996;87:1958–1989.

    Google Scholar 

  13. Hintzen RQ, van Lier RAW, Kuijpers KC, et al. Elevated levels of a soluble form of the T cell activation antigen CD27 in cerebrospinal fluid of multiple sclerosis patients.J Neuroimmunol. 1991;35:211–217.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medical Oncology, Cukurova University Faculty of Medicine, 013330, Adana, Turkey

    Ismail Oguz Kara MD (Assoc Prof) & Berksoy Sahin MD (Prof)

  2. Department of Rheumatology-Immunology, Cukurova University Faculty of Medicine, Adana, Turkey

    Ramazan Gunesacar MD

Authors
  1. Ismail Oguz Kara MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Berksoy Sahin MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ramazan Gunesacar MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ismail Oguz Kara MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kara, I.O., Sahin, B. & Gunesacar, R. Levels of serum and cerebrospinal fluid soluble CD27 in the diagnosis of leptomeningeal involvement of hematolymphoid malignancies. Adv Therapy 24, 741–747 (2007). https://doi.org/10.1007/BF02849967

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02849967

Keywords

Search

Navigation